The pharmaceutical industry faces mounting challenges, including rising clinical trial costs, growing data complexity, and declining ROI. Artificial Intelligence (AI) offers transformative solutions by accelerating drug discovery, optimizing clinical trials, and enhancing R&D efficiency. India, with its vast talent pool and 95+ Global Capability Centres (GCCs), is emerging as a global leader in AI-driven pharma innovation. These centres, backed by robust infrastructure and regulatory support, are advancing drug development, attracting over $7 billion in investments, and shaping the future of healthcare.